newsfilter
← Latest News
GlobeNewswire·

Athira Pharma Announces Upcoming Presentations at the American Academy of Neurology (AAN) 2023 Annual Meeting

Oral presentation to highlight additional clinical data from Phase 2 ACT-AD trial of fosgonimeton in mild-to-moderate Alzheimer's disease patients including improvements in measures of cognition and plasma biomarkers